Delayed
Bombay S.E.
04:11:45 2024-07-12 am EDT
|
5-day change
|
1st Jan Change
|
12.3
INR
|
-0.08%
|
|
-0.89%
|
+0.90%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,175
|
928.1
|
316.5
|
320.9
|
248.5
|
185
|
Enterprise Value (EV)
1 |
1,295
|
1,061
|
444.9
|
479.5
|
417.3
|
355.3
|
P/E ratio
|
23.5
x
|
17.1
x
|
21.3
x
|
-5.8
x
|
-3.86
x
|
18.4
x
|
Yield
|
0.33%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.72
x
|
1.44
x
|
0.6
x
|
0.73
x
|
1.24
x
|
0.82
x
|
EV / Revenue
|
1.9
x
|
1.65
x
|
0.85
x
|
1.09
x
|
2.09
x
|
1.58
x
|
EV / EBITDA
|
17.1
x
|
12.8
x
|
11.6
x
|
-14.2
x
|
-9.15
x
|
11.1
x
|
EV / FCF
|
-27.2
x
|
-19.7
x
|
-51.3
x
|
-41.3
x
|
78.5
x
|
-70.4
x
|
FCF Yield
|
-3.68%
|
-5.07%
|
-1.95%
|
-2.42%
|
1.27%
|
-1.42%
|
Price to Book
|
4.37
x
|
2.69
x
|
0.86
x
|
1.03
x
|
1.01
x
|
0.72
x
|
Nbr of stocks (in thousands)
|
39,245
|
39,245
|
40,215
|
40,215
|
40,215
|
40,215
|
Reference price
2 |
29.95
|
23.65
|
7.870
|
7.980
|
6.180
|
4.600
|
Announcement Date
|
8/30/18
|
9/3/19
|
10/6/20
|
9/9/21
|
9/8/22
|
9/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
682.9
|
644.2
|
524.5
|
440.3
|
200
|
225.4
|
EBITDA
1 |
75.82
|
82.85
|
38.28
|
-33.76
|
-45.61
|
31.93
|
EBIT
1 |
68.25
|
74.46
|
29.29
|
-42.2
|
-52.59
|
26.31
|
Operating Margin
|
9.99%
|
11.56%
|
5.58%
|
-9.59%
|
-26.29%
|
11.67%
|
Earnings before Tax (EBT)
1 |
55.99
|
63.88
|
14.53
|
-56.54
|
-65.58
|
9.646
|
Net income
1 |
49.37
|
54.46
|
15.01
|
-55.03
|
-64.61
|
10.12
|
Net margin
|
7.23%
|
8.45%
|
2.86%
|
-12.5%
|
-32.31%
|
4.49%
|
EPS
2 |
1.277
|
1.380
|
0.3700
|
-1.376
|
-1.600
|
0.2500
|
Free Cash Flow
1 |
-47.63
|
-53.79
|
-8.667
|
-11.6
|
5.315
|
-5.045
|
FCF margin
|
-6.97%
|
-8.35%
|
-1.65%
|
-2.64%
|
2.66%
|
-2.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/30/18
|
9/3/19
|
10/6/20
|
9/9/21
|
9/8/22
|
9/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
119
|
133
|
128
|
159
|
169
|
170
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.572
x
|
1.6
x
|
3.356
x
|
-4.697
x
|
-3.7
x
|
5.334
x
|
Free Cash Flow
1 |
-47.6
|
-53.8
|
-8.67
|
-11.6
|
5.31
|
-5.04
|
ROE (net income / shareholders' equity)
|
20.2%
|
17.7%
|
4.21%
|
-16.2%
|
-23.1%
|
4.01%
|
ROA (Net income/ Total Assets)
|
8.81%
|
7.67%
|
2.64%
|
-3.9%
|
-5.38%
|
2.8%
|
Assets
1 |
560.1
|
709.7
|
567.9
|
1,410
|
1,200
|
360.9
|
Book Value Per Share
2 |
6.850
|
8.780
|
9.120
|
7.750
|
6.150
|
6.400
|
Cash Flow per Share
2 |
0.0900
|
0.0800
|
0.0400
|
0.0200
|
0.0400
|
0.0100
|
Capex
1 |
17.1
|
13
|
10.3
|
3.04
|
6.12
|
0.67
|
Capex / Sales
|
2.5%
|
2.02%
|
1.96%
|
0.69%
|
3.06%
|
0.3%
|
Announcement Date
|
8/30/18
|
9/3/19
|
10/6/20
|
9/9/21
|
9/8/22
|
9/4/23
|
|
1st Jan change
|
Capi.
|
---|
| +0.90% | 5.93M | | -14.24% | 3.03B | | -43.74% | 1.51B | | -13.93% | 1.46B | | -19.66% | 1.46B | | -34.15% | 1.41B | | -8.35% | 1.04B | | +60.35% | 918M | | -33.75% | 875M | | -22.47% | 800M |
Pesticide
|